EcoDrugPlus

Nad(P)h Quinone Dehydrogenase 1

Ensembl ID : ENSSLUG00000000876
Gene Symbol: NQO1
3 Cross references
164 Possible Orthologues:

Nadph Oxidase 4

Ensembl ID : ENSSLUG00000008560
Gene Symbol: NOX4
1 Cross references
151 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSSLUG00000025186
Gene Symbol: NPC1L1
1 Cross references
189 Possible Orthologues:

P2x Purinoceptor 3-Like

Ensembl ID : ENSSLUG00000000204
Gene Symbol: LOC116052412
3 Cross references
192 Possible Orthologues:

P2y Purinoceptor 12-Like

Ensembl ID : ENSSLUG00000019481
Gene Symbol: LOC116050827
3 Cross references
180 Possible Orthologues:

Ptk6 Protein Tyrosine Kinase 6b

Ensembl ID : ENSSLUG00000013364
Gene Symbol: PTK6B
1 Cross references
159 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSSLUG00000025048
Gene Symbol: PIM3
3 Cross references
172 Possible Orthologues:

Rac-Beta Serine/threonine-Protein Kinase

Ensembl ID : ENSSLUG00000009227
Gene Symbol: LOC116046534
3 Cross references
210 Possible Orthologues:

Rac-Beta Serine/threonine-Protein Kinase-Like

Ensembl ID : ENSSLUG00000004147
Gene Symbol: LOC116063150
3 Cross references
161 Possible Orthologues:

Rac-Gamma Serine/threonine-Protein Kinase

Ensembl ID : ENSSLUG00000012742
Gene Symbol: LOC116056540
3 Cross references
203 Possible Orthologues:

Rela Proto-Oncogene, Nf-Kb Subunit

Ensembl ID : ENSSLUG00000014087
Gene Symbol: RELA
3 Cross references
199 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSSLUG00000002257
Gene Symbol: RAF1
3 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).